Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues.
First-quarter worldwide sales increased 9% year-over-year to $15.8 billion, mainly reflecting sustained growth across the oncology and vaccine portfolios.
The company reported a net profit of $4.76 billion or $1.87 per share for the March quarter, compared to $2.82 billion or $1.11 per share in the prior-year period. On an adjusted basis, earnings climbed to $2.07 per share in Q1 from $1.40 per share in the first quarter of 2023.
“Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our deep pipeline and are maximizing the impact of our broad commercial portfolio for the benefit of patients,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from Micron’s (MU) first-quarter 2026 results
Micron Technology Inc. (NASDAQ: MU) has reported blockbuster first-quarter results, comfortably beating estimates as strength in data center demand pushed key operating metrics to record levels. Management is now focused
Lennar (LEN) continues to battle a stubbornly difficult housing market
Shares of Lennar Corporation (NYSE: LEN) were down 2% on Thursday. The stock has dropped 17% over the past three months. The homebuilder saw its revenues and profits decline in
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
